Cost-effectiveness analysis of ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy for intermediate- to high-risk localized prostate cancer

BACKGROUND: Radiotherapy is an effective curative treatment option for intermediate- to high-risk localized prostate cancer. According to the HYPO-RT-PC trial (ISRCTN45905321), there was no significant difference in 5 years of follow-up in terms of failure-free survival, overall survival, urinary to...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jiaoxue, Wang, Qingfeng, Hu, Qiancheng, Li, Changlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883113/
https://www.ncbi.nlm.nih.gov/pubmed/36713549
http://dx.doi.org/10.3389/fonc.2022.841356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883113/
https://www.ncbi.nlm.nih.gov/pubmed/36713549
http://dx.doi.org/10.3389/fonc.2022.841356

Ejemplares similares